One to watch, page-3

First 3 Last

Share
Profile

Follow
sigmadelta

6,789 Posts.

147

21/02/18

21:26

Post #: 31237180
Share

Originally posted by chelkn ↑

Wow, sweet. So we potentially double the amount of shares via AIM, diluting long term holders to oblivion when the share price is at it's lowest. Then CAS management sets about raising the share price in 2H18! Only CAS management could come up with a genius strategy like that!

He's an unorthadox approach. Set about a reversal of the share price FIRST by reinstilling confidence in the stock. This is directed towards CAS management:

- Show a practical game plan that leads to production. (most punters don't believe what CAS says anymore since any historic timetable is laughable. You need to somewhere win back respect which has evaporated over the last few years)

-Do as you say. If you set a goal in a time period -- DO IT! Be the company that under promises and over deliveries. Not the one that over promises and under deliveries. (Your reputation is shot, only hard work will turn that around)

-Set about a REDUCTION in admin costs. You're a small cap.... and getting smaller and smaller by the day. Remember that fact or you'll soon be a micro cap with a army of personnel at your disposal. (does that make any sense? Well it doesn't to your competitors. You know the ones, they're the ones on the top of the peer comparison charts in any EV comparison of ounce to market cap)

Get your house in order FIRST, show you're the real deal, turn around the share price FIRST, get the share price trending upwards FIRST. And THEN worry about a AIM listing.

You seem to be desperate by doing it this way. Are you?

Expand

Englebrecht has mates in London who are just dying to cannibalise companies that are at risk. From an ex Stratex shareholder.

CAS Price at posting: 6.6¢ Sentiment: None Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer’s drug could change the game

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

GRL

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

LPE

Sales growth pushes Lovisa's fortunes (and shares) upwards

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

HotCopper Highlights: Your most watched stocks for Week 47, 2024

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

SIG

Dale Gillham's weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse

Week 47 Wrap: HotCopper users' most watched; Brent lifts on Putin's scary letter; RFK dents CSL

First 3 Last

Add CAS (ASX) to my watchlist

One to watch, page-3

Top Stories

This biotech stock raised $11M in a risk-off environment. Its Alzheimer’s drug could change the game

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Sales growth pushes Lovisa's fortunes (and shares) upwards

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

HotCopper Highlights: Your most watched stocks for Week 47, 2024

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Dale Gillham's weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse

Week 47 Wrap: HotCopper users' most watched; Brent lifts on Putin's scary letter; RFK dents CSL

Featured News